{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "BA.5",
      "COVID-19",
      "Omicron",
      "SARS-CoV-2",
      "recombinant",
      "vaccine"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "36619228",
  "DateCompleted": {
    "Year": "2023",
    "Month": "01",
    "Day": "10"
  },
  "DateRevised": {
    "Year": "2023",
    "Month": "01",
    "Day": "11"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2023",
        "Month": "01",
        "Day": "01"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.7150/ijms.79116"
    ],
    "Journal": {
      "ISSN": "1449-1907",
      "JournalIssue": {
        "Volume": "20",
        "Issue": "1",
        "PubDate": {
          "Year": "2023"
        }
      },
      "Title": "International journal of medical sciences",
      "ISOAbbreviation": "Int J Med Sci"
    },
    "ArticleTitle": "Characterization of SARS-CoV-2 recombinants and emerging Omicron sublineages.",
    "Pagination": {
      "StartPage": "151",
      "EndPage": "162",
      "MedlinePgn": "151-162"
    },
    "Abstract": {
      "AbstractText": [
        "The SARS-CoV-2 Omicron is currently the predominant circulating variant in the COVID-19 pandemic. The dominating Omicron sublineages respond to host immune pressure and develop advantageous mutations or genetic recombination, which result in variants that are more contagious or better at escaping immune responses in response to previous infection or vaccination. Meanwhile, multiple genetic recombination events have been reported in coinfection cases, the majority of which have resulted from the recombination between co-circulating Omicron BA.1 (or BA.1.1) and Delta variant or BA.2. Here, we review the knowledge and characterization of recombination for SARS-CoV-2 at the population level, provide an update on the occurrence of newly circulating Omicron sublineages, and discuss the effectiveness of novel vaccines/therapeutic drugs against the Omicron variant."
      ],
      "CopyrightInformation": "\u00a9 The author(s)."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China."
          }
        ],
        "LastName": "Wang",
        "ForeName": "Yuliang",
        "Initials": "Y"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China."
          }
        ],
        "LastName": "Long",
        "ForeName": "Yiyin",
        "Initials": "Y"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Genetics, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China."
          }
        ],
        "LastName": "Wang",
        "ForeName": "Feng",
        "Initials": "F"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China."
          }
        ],
        "LastName": "Li",
        "ForeName": "Changlin",
        "Initials": "C"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Tianjin Children's Hospital, Children's Hospital, Tianjin University, Tianjin, China."
          }
        ],
        "LastName": "Liu",
        "ForeName": "Wei",
        "Initials": "W"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Australia",
    "MedlineTA": "Int J Med Sci",
    "NlmUniqueID": "101213954",
    "ISSNLinking": "1449-1907"
  },
  "SupplMeshList": [
    "SARS-CoV-2 variants"
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "genetics"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [
        "epidemiology"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Pandemics"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Coinfection"
    }
  ],
  "CoiStatement": "Competing Interests: The authors have declared that no competing interest exists."
}